India · Delayed Price · Currency is INR Sanofi India Statistics
Total Valuation
Sanofi India has a market cap or net worth of INR 81.12 billion. The enterprise value is 78.67 billion.
| Market Cap | 81.12B |
| Enterprise Value | 78.67B |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Apr 22, 2026 |
Share Statistics
Sanofi India has 23.03 million shares outstanding.
| Current Share Class | 23.03M |
| Shares Outstanding | 23.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 24.56% |
| Float | 9.07M |
Valuation Ratios
The trailing PE ratio is 24.83 and the forward PE ratio is 20.86.
| PE Ratio | 24.83 |
| Forward PE | 20.86 |
| PS Ratio | 4.41 |
| PB Ratio | 10.83 |
| P/TBV Ratio | 10.84 |
| P/FCF Ratio | 19.66 |
| P/OCF Ratio | 18.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.01, with an EV/FCF ratio of 19.07.
| EV / Earnings | 24.08 |
| EV / Sales | 4.28 |
| EV / EBITDA | 16.01 |
| EV / EBIT | 17.32 |
| EV / FCF | 19.07 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.63 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 267.24 |
Financial Efficiency
Return on equity (ROE) is 40.59% and return on invested capital (ROIC) is 67.12%.
| Return on Equity (ROE) | 40.59% |
| Return on Assets (ROA) | 19.81% |
| Return on Invested Capital (ROIC) | 67.12% |
| Return on Capital Employed (ROCE) | 59.51% |
| Weighted Average Cost of Capital (WACC) | 5.24% |
| Revenue Per Employee | 16.75M |
| Profits Per Employee | 2.98M |
| Employee Count | 1,097 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, Sanofi India has paid 1.18 billion in taxes.
| Income Tax | 1.18B |
| Effective Tax Rate | 26.53% |
Stock Price Statistics
The stock price has decreased by -43.05% in the last 52 weeks. The beta is 0.18, so Sanofi India's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -43.05% |
| 50-Day Moving Average | 3,723.37 |
| 200-Day Moving Average | 4,597.36 |
| Relative Strength Index (RSI) | 51.55 |
| Average Volume (20 Days) | 1,786 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi India had revenue of INR 18.37 billion and earned 3.27 billion in profits. Earnings per share was 141.85.
| Revenue | 18.37B |
| Gross Profit | 9.27B |
| Operating Income | 4.54B |
| Pretax Income | 4.45B |
| Net Income | 3.27B |
| EBITDA | 4.86B |
| EBIT | 4.54B |
| Earnings Per Share (EPS) | 141.85 |
Balance Sheet
The company has 2.63 billion in cash and 178.00 million in debt, with a net cash position of 2.45 billion or 106.42 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 178.00M |
| Net Cash | 2.45B |
| Net Cash Per Share | 106.42 |
| Equity (Book Value) | 7.49B |
| Book Value Per Share | 325.31 |
| Working Capital | 3.09B |
Cash Flow
In the last 12 months, operating cash flow was 4.38 billion and capital expenditures -257.00 million, giving a free cash flow of 4.13 billion.
| Operating Cash Flow | 4.38B |
| Capital Expenditures | -257.00M |
| Depreciation & Amortization | 319.00M |
| Net Borrowing | -43.00M |
| Free Cash Flow | 4.13B |
| FCF Per Share | 179.15 |
Margins
Gross margin is 50.46%, with operating and profit margins of 24.73% and 17.78%.
| Gross Margin | 50.46% |
| Operating Margin | 24.73% |
| Pretax Margin | 24.20% |
| Profit Margin | 17.78% |
| EBITDA Margin | 26.46% |
| EBIT Margin | 24.73% |
| FCF Margin | 22.46% |
Dividends & Yields
This stock pays an annual dividend of 123.00, which amounts to a dividend yield of 3.49%.
| Dividend Per Share | 123.00 |
| Dividend Yield | 3.49% |
| Dividend Growth (YoY) | 5.13% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 135.35% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.55% |
| Earnings Yield | 4.03% |
| FCF Yield | 5.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sanofi India has an Altman Z-Score of 18.39 and a Piotroski F-Score of 6.
| Altman Z-Score | 18.39 |
| Piotroski F-Score | 6 |